Hotline:
+ 49 (0) 2204 2918806
Reports By Company
SWOT- reports aim at demonstrating a company’s strengths, weaknesses, opportunities and threats. The reports cover both annual balance and income statement and discus topics regarding profit appropriation and the supervisory board. A business report informs about the company and therefore influences prospective actions. Apart from SWOT-reports, there are also reports about building projects to be found in this category.
Subscribe to RSS Feed

Market studies for category Reports By Company

Items 1 to 10 of 1209 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 121
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    34 pages
    Global Market Direct’s pharmaceuticals report, “Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2013” provides data on the Protalix BioTherapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dor
    Englisch | Zukunftsanalyse | SKU: 361776
  3. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    DiaMedica Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    36 pages
    Global Markets Direct’s pharmaceuticals report, “DiaMedica Inc. - Product Pipeline Review - 2013” provides data on the DiaMedica Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is b
    Englisch | Zukunftsanalyse | SKU: 355083
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Applied Immune Technologies Ltd - Product Pipeline Review - 2013

    Global Markets Direct
    16 pages
    Global Market Direct’s pharmaceuticals report, “Applied Immune Technologies Ltd - Product Pipeline Review - 2013” provides data on the Applied Immune Technologies Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and d
    Englisch | Zukunftsanalyse | SKU: 354795
  5. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Ziarco Pharma Ltd - Product Pipeline Review - 2013

    Global Markets Direct
    26 pages
    Global Market Direct’s pharmaceuticals report, “Ziarco Pharma Ltd - Product Pipeline Review - 2013” provides data on the Ziarco Pharma Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report
    Englisch | Zukunftsanalyse | SKU: 361840
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Chroma Therapeutics Ltd. – Product Pipeline Review – 2013

    Global Markets Direct
    41 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Chroma Therapeutics Ltd. - Product Pipeline Review - 2013” provides data on the Chroma Therapeutics Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and do
    Englisch | Report | SKU: 329967
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2013

    Global Markets Direct
    47 pages
    Global Markets Direct’s, 'Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Functional (Non Ulcer) Dyspepsia, complete with latest updates, and special features on late-stage and discontinued p
    Englisch | Zukunftsanalyse | SKU: 355147
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Diabetic Gastroparesis - Pipeline Review, H2 2013

    Global Markets Direct
    39 pages
    Global Markets Direct’s, 'Diabetic Gastroparesis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Gastroparesis, complete with latest updates, and special features on late-stage and discontinued projects. It also rev
    Englisch | Zukunftsanalyse | SKU: 354859
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    House Dust Mite Allergy - Pipeline Review, H2 2013

    Global Markets Direct
    52 pages
    Global Markets Direct’s, 'House Dust Mite Allergy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for House Dust Mite Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also r
    Englisch | Zukunftsanalyse | SKU: 361904
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    ManRos Therapeutics – Product Pipeline Review – 2013

    Global Markets Direct
    18 pages
    Introduction Global Market Direct’s pharmaceuticals report, “ManRos Therapeutics - Product Pipeline Review - 2013” provides data on the ManRos Therapeutics’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant proj
    Englisch | Report | SKU: 330031
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2013

    Global Markets Direct
    49 pages
    Global Markets Direct’s, 'Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), compl
    Englisch | Zukunftsanalyse | SKU: 355211

Items 1 to 10 of 1209 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 121